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1. Introduction
Nephrotic cystinosis is an autosomally determined recessive 
genetic disorder that results from a defect in the lysosomal 
effl ux of cystine. This is caused by mutations in the gene, 
CTNS, that encodes the transporter cystinosin, which 
mediates the effl ux of cystine from the lysosome to the 
cytosol. A defect in the CTNS gene leads to a high level
of cystine accumulation in the lysosome (Town et al. 
1998). The clinical symptoms are varied and although 
cystine accumulation is observed in the cells of all organs,
it is primarily the kidney that is most severely affected,
where a severe renal proximal tubular dysfunction is seen 
(renal Fanconi syndrome). If untreated in children, it
can limit their lifespan to about 10 years. Current therapy 
includes cystine-depleting therapy (using cysteamine)
and renal transplantation (Gahl et al. 1987, 2001). However, 
neither treatment leads to complete recovery. A mouse
model has been created by homozygous knockouts of
the CTNS gene, and these ctns-/ctns- mice showed
cystine accumulation in all organs. However, while
the mice displayed ocular and other symptoms of the
disease, surprisingly, they did not show proximal tubular 
dysfunction in the kidney or renal failure (Cherqui et al. 
2002). Using the mouse model, bone marrow transplantations 
were recently performed and shown to be very successful 
in the treatment of the disease in mice, raising hopes for 
a similar treatment being eventually possible in humans 
(Syres et al. 2009).
Several investigations over the past several years have been 
directed towards understanding how increased lysosomal 
cystine leads to the clinical symptoms and subsequent 
manifestations. However, despite many years of study,
the pathophysiology of the disease is still not properly 
http://www.ias.ac.in/jbiosci J. Biosci. 35(1), March 2010, 21–25, © Indian Academy of Scien es    21
Brief communication
A futile cycle, formed between two ATP-dependant γ-glutamyl cycle 
enzymes, γ-glutamyl cysteine synthetase and 5-oxoprolinase: the cause of 
cellular ATP depletion in nephrotic cystinosis?
AKHILESH KUMAR and ANAND KUMAR BACHHAWAT*
Institute of Microbial Technology, Sector 39-A, Chandigarh 160 036, India
*Corresponding author (Fax, 0172-2690632; Email, anand@imtech.res.in; anand.bachhawat@gmail.com)
Cystinosis, an inherited disease caused by a defect in the lysosomal cystine transporter (CTNS), is characterized 
by renal proximal tubular dysfunction. Adenosine triphosphate (ATP) depletion appears to be a key event in the 
pathophysiology of the disease, even though the manner in which ATP depletion occurs is still a puzzle. We present a 
model that explains how a futile cycle that is generated between two ATP-utilizing enzymes of the γ-glutamyl cycle 
leads to ATP depletion. The enzyme γ-glutamyl cysteine synthetase (γ-GCS), in the absence of cysteine, forms 5-
oxoproline (instead of the normal substrate, γ-glutamyl cysteine) and the 5-oxoproline is converted into glutamate 
by the ATP-dependant enzyme, 5-oxoprolinase. Thus, in cysteine-limiting conditions, glutamate is cycled back into 
glutamate via 5-oxoproline at the cost of two ATP molecules without production of glutathione and is the cause of 
the decreased levels of glutathione synthesis, as well as the ATP depletion observed in these cells. The model is also 
compatible with the differences seen in the human patients and the mouse model of cystinosis, where renal failure is 
not observed.
[Kumar A and Bachhawat A K 2010 A futile cycle, formed between two ATP-dependant γ-glutamyl cycle enzymes, γ-glutamyl cysteine synthetase 
and 5-oxoprolinase: the cause of cellular ATP depletion in nephrotic cystinosis?; J. Biosci. 35 21–25] DOI 10.1007/s12038-010-0004-8
Keywords. ATP depletion; cysteine synthetase; cystinosis; γ-glutamyl cycle; γ-glutamyl glutathione; 5-oxoproline 
Abbreviations used: ADP, adenosine diphosphate; ATP, adenosine triphosphate; CDME, cystine dimethyl ester; CTNS, cystine transporter; 
γ-GCS, γ-glutamyl cysteine synthetase; γ-GT, gamma-glutamyl transpeptidase
Akhilesh Kumar and Anand Kumar Bachhawat22
J. Biosci. 35(1), March 2010
understood (Baum 1998; Nesterova and Gahl 2008; Wilmer 
et al. 2008). 
One suggested mechanism by which intralysosomal 
cystine accumulation is linked to the clinical manifestations 
is that the increased cystine levels in the lysosome lead 
to enhanced apoptosis. This has been based on the 2–4-
fold increased rate of apoptosis seen in cystinotic cells,
which is reversed when cysteamine treatment decreases
the lysosomal cystine levels. It has been suggested that 
during the early stages of apoptosis when the lysosomal 
membrane is permeabilized, large amounts of cystine exit 
the lysosome to enter the cytosol and positively affect the 
proapoptotic proteins (such as protein kinase Cδ) leading 
to enhanced apoptosis (Park et al. 2002, 2006; Park and 
Thoene 2005). 
A second mechanism that may explain the biochemical 
basis for the pathophysiology is based on the observation 
that lysosomal cystine accumulation leads to cellular
ATP depletion. ATP depletion in cystinosis was fi rst 
observed in a cystinosis model (based on loading lysosomes 
with cystine by cystine dimethyl ester, CDME) (Coor et al. 
1991). In this study, it was also further suggested that the
decreased ATP in cystinotic cells would lead to a decrease 
in Na+K+-ATPase activity. As this pump generates a 
Na+ gradient that allows reabsorption of amino acids, 
phosphate, glucose and other solutes in the proximal tubules 
of the kidney, defective pumping owing to decreased 
ATP levels would decrease uptake and thus lead to the 
severe phenotypes. As the CDME model of cystinosis is 
not a fully acceptable model owing to the oxidative stress 
induced by CDME itself, fi broblast cells from cystinotic 
patients have also been used to investigate the disease. It 
was observed that signifi cant ATP depletion also occurs in 
cystinotic fi broblast cells (Levtchenko et al. 2006; Wilmer 
et al. 2008). However, whether ATP depletion is a triggering 
factor leading to the clinical manifestations has not been 
conclusively established.
2. An integrated explanation to link the intralysosomal 
accumulation of cystine and the different observations 
made in nephrotic cystinosis with the pathophysiology is 
currently missing
The cause behind the decreased ATP levels seen in cystinotic 
cells was initially thought to be a consequence of a defect 
in mitochondrial ATP-generating capacity due to the 
mitochondria possibly becoming dysfunctional in these cells 
(Baum 1998). However, recent studies have clearly shown 
that there is no defect in the mitochondrial ATP-generating 
capacity in cystinotic fi broblasts (Levtchenko et al. 2006; 
Wilmer et al. 2008).
So how does ATP depletion occur? Despite ATP depletion 
being an important and possibly key phenomenon in 
cystinotic cells, the mechanism by which ATP is depleted 
in these cells continues to remain a puzzle. Among the 
possibilities that have been speculated upon include 
increased ATP consumption or altered glycolysis, but neither 
of these possibilities have yet been experimentally evaluated 
(Wilmer et al. 2008). 
In addition to ATP depletion, cystinotic cells have 
also been found to have lower levels of glutathione
that also might enhance apoptosis in these cells (Laube et 
al. 2006). Furthermore, the levels of cysteine in the cytosol
of cystinotic cells are actually lower than normal, despite 
these cells having high levels of intralysosomal cystine.
In the presence of high levels of cystine, measuring 
the cytosolic cysteine levels has actually been diffi cult; 
however, the ability of cysteine precursors to refurbish 
the low glutathione levels of these cells to normal levels 
suggests that cytosolic cysteine is indeed limiting in these 
cells (Chol et al. 2004; Mannucci et al. 2006). Cysteine is 
the most limiting nutrient in the glutathione biosynthetic 
pathway, and it appears that in cystinotic cells they are 
signifi cantly more limiting (Lu 1999). This is because the 
lysosomal cystine which is likely to be a pool for cytosolic 
cysteine is no more available to the cells, thereby leading to 
cysteine defi ciency conditions in the cell despite the high 
levels of intralysosomal cystine.
Another intriguing observation in patients with 
nephropathic cystinosis is the almost 60-fold higher
levels of 5-oxoproline (pyroglutamic acid) detected in 
the urine of these patients (Rizzo et al. 1999). These high 
levels of 5-oxoproline were found to return to normal 
levels when these patients were subjected to cysteamine 
therapy. The excess 5-oxoproline has been explained
as being due to a defect in the γ-glutamyl cycle
(Mannucci et al. 2006). However, how a defective
γ-glutamyl cycle could lead to 5-oxoproline secretion has 
not been explained. 5-oxoprolinuria (pyroglutamicaciduria) 
has otherwise been observed in patients who lack the
5-oxoprolinase enzyme or the second enzyme of glutathione 
biosynthesis (glutathione synthase) (Ristoff and Larsson 
2007).
Thus, several aspects of nephrotic cystinosis remain 
unexplained. Any hypothesis or mechanism that seeks
to explain how cystine accumulation in the lysosome
leads to the downstream pathogenic events also needs 
to integrate several different observations: (i) the ATP 
depletion seen in cystinotic cells although the mitochondrial 
ATP-generating capacity is intact; (ii) increased levels
of apoptosis seen in cystinotic cells; (iii) decreased 
glutathione levels; (iv) secretion of high levels of
5-oxoproline; and (v) the severe manifestations of the 
disease specifi cally seen in the kidney even though cystine 
accumulates in the lysosomes of other organs to almost 
similar extents.
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3. A futile cycle formed between two ATP-requiring 
enzymes of the γ-glutamyl cycle as a result of 
intralysosomal cystine accumulation can explain ATP 
depletion and other observations made in nephrotic 
cystinosis
In the present article, we put forward a hypothesis to 
explain how ATP depletion might occur in cystinotic cells. 
We propose that ATP depletion results from the formation 
of a futile cycle involving two ATP-dependant γ-glutamyl 
cycle enzymes, γ-GCS and 5-oxoprolinase, leading to the 
continuous depletion of 2 molecules of ATP per cycle. 
Interestingly, the hypothesis also succeeds in integrating all 
the other observations seen in cystinosis and is explained 
below.
The enzyme γ-GCS (also known as glutamate-cysteine 
ligase) is the fi rst enzyme and the regulated step in glutathione 
biosynthesis. The reaction involves ligation of glutamate to 
cysteine and is mediated by ATP leading to the formation of 
γ-glutamylcysteine (Snoke and Bloch 1954). Investigations 
into the mechanism of the reaction have revealed that the 
reaction mechanism involves the formation of activated 
glutamyl phospate. This intermediate remains in the active 
site before it attacks the second substrate cysteine leading 
to the removal of phosphate from the glutamate residue and 
the formation of γ-glutamyl cysteine, adenosine diphosphate 
(ADP) and Pi. Interestingly, it has also been shown that the 
enzyme γ-GCS, if it fails to fi nd the acceptor (cysteine) 
for γ-glutamyl phosphate, can autocyclize the activated γ-
glutamyl phosphate to form 5-oxoproline (pyroglutamate) 
(Orlowski and Meister 1971). 
The sequential events leading to ATP depletion 
in cystinosis can thus be explained as follows. As a 
consequence of the defective cystinosin gene, the cell is 
unable to get suffi cient levels of cytosolic cysteine. This 
can result in the formation of 5-oxoproline through the 
partial reaction of the γ-GCS enzyme as described above. 
5-oxoproline, which is a normal metabolite of the γ-glutamyl 
cycle, can be acted upon by the action of the 5-oxoprolinase 
enzyme (another ATP-requiring enzyme) to yield glutamate 
(Van der Werf et al. 1971). Thus, glutamate is cycled by 
the action of two consecutive ATP-dependant enzymes 
to yield back glutamate (at the expense of two molecules 
of ATP). However, 5-oxoprolinase is known to be a very 
ineffi cient enzyme (being one of the most sluggish enzymes 
known with a reaction rate of 0.45 nmol/h) (Watanabe et al. 
2004) and it is likely that not all the 5-oxoproline generated
by this reaction would be converted back into glutamate. 
Increased levels of 5-oxoproline would thereby accumulate 
in the cells and the excess would be secreted. This explains 
the high levels of 5-oxoproline observed in the urine 
of patients with nephrotic cystinosis (Rizzo et al.1999; 
Mannucci et al. 2006). The glutamate that is cycled
back can once again feed into the γ-GCS enzyme leading 
again to the formation of 5-oxoproline in the absence of 
suffi cient amounts of cytosolic cysteine. Thus, by the 
continuous action of the ATP-dependant γ-GCS and the 
ATP-dependant 5-oxoprolinase, the cell is forced into a 
futile cycle leading to ATP depletion. Furthemore, as the 
cellular glutathione levels are low (owing to lower cytosolic 
cysteine levels), feedback inhibition of γ-GCS by glutathione 
would be reduced (Richman and Meister 1975). This would 
result in greater activity of the enzyme and increase cycling 
through the futile cycle, thereby leading to continuous ATP 
depletion. The reduced levels of glutathione in cystinosis 
could also be a major contributor to the higher rate of 
apoptosis in cystinotic cells, as proposed earlier (Laube et 
al. 2006).
The highly active γ-glutamyl cycle in the kidney explains 
the severe renal phenotypes in nephrotic cystinosis. The 
γ-glutamyl cycle is highly active in the kidney (Meister 
1973; Griffi th and Meister 1979) since glutathione needs to 
be made at signifi cant levels for handling the electrophiles 
encountered, and has also to be effl uxed outside the cell 
(Lash 2005a, b) to allow for amino acid reabsorption 
through γ-glutamyl transpeptidase. γ-GCS constitutes
up to 2–3% of the total kidney protein (Meister 1973).
This, and the fact that signifi cant amounts of ATP are
needed in these cells for reabsorption of solutes, suggests 
why the kidney is the most severely affected organ in 
cystinosis. ATP depletion could lead to malfunctioning 
of Na+K+-ATPase, leading to problems in reabsorption 
from the proximal tubules and the consequent effects that 
account for some of the clinical symptoms seen in nephrotic 
cystinosis, as proposed earlier (Coor et al. 1991). Treatment 
with cysteamine leads to release of cysteine into the 
cytosol, and the release of cysteine consequently prevents 
the channelling of ATP into a futile cycle. This can restore 
the ATP levels, stop excess 5-oxoproline formation, and 
also restore glutathione levels, thereby preventing further 
progression of the disease. 
4. The higher γ-glutamyl transpeptidase activity in 
rodent kidneys (as compared to humans) explains the 
absence of the severe renal phenotype in ctns-/ctns- mice
Finally, why is it that cystinosis leads to severe renal defects 
and proximal tubulopathy in humans, but renal failure is 
not seen in the cystinosis model of mice? A comparison 
of the enzymes of glutathione degradation in rats, pigs and 
primates carried out some years ago revealed that in rat, 
renal activity of membrane-bound γ-glutamyl transpeptidase 
(γ-GT) (that initiates glutathione degradation) was far higher 
than in humans, and therefore the rat was not found to be a 
good model for studying glutathione catabolism in humans 
(Hinchman and Ballatori 1995). However, importantly, a 
high renal γ-GT in rats would allow extracellular glutathione 
(from plasma/glomerular fi ltrates) to be degraded at
much higher levels (compared with humans) leading to 
increased cytosolic cysteine through the action of γ-GT
and the cys-gly dipetidases (fi gure 1). Interorgan glutathione 
transport is considered to be an important form of cysteine 
transport (Lash 2005b). The relatively higher cytosolic 
cysteine levels that would be available in kidney cells
(of rat or mice) from this route would prevent the
action of the futile cycle from operating even in cystinotic 
mice, thereby preventing ATP depletion and the consequent 
severe renal proximal tubulopathy. The futile cycle 
hypothesis thus also succeeds in explaining the differences 
seen in human patients with cystinosis and the mouse model 
of cystinosis.
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